Sarepta Therapeutics, Inc. - Common Stock (SRPT)
CUSIP: 803607100
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 104,849,534
- Total 13F shares
- 65,753,485
- Share change
- +1,161,885
- Total reported value
- $6,079,879,477
- Put/Call ratio
- 85%
- Price per share
- $92.48
- Number of holders
- 297
- Value change
- +$130,063,243
- Number of buys
- 146
- Number of sells
- 160
Quarterly Holders Quick Answers
What is CUSIP 803607100?
CUSIP 803607100 identifies SRPT - Sarepta Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 803607100:
Top shareholders of SRPT - Sarepta Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
7.1%
|
7,456,402
|
$579,661,000 | — | 30 Jun 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
6.6%
|
6,894,765
|
$536,015,000 | — | 30 Jun 2021 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.3%
|
5,607,148
|
$435,900,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.6%
|
4,866,350
|
$378,310,000 | — | 30 Jun 2021 | |
| Capital Research Global Investors |
13F
|
Company |
4.5%
|
4,750,769
|
$369,325,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
4.2%
|
4,427,197
|
$344,171,000 | — | 30 Jun 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
2.3%
|
2,400,000
|
$186,576,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.9%
|
1,980,788
|
$153,987,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
1,686,345
|
$131,096,000 | — | 30 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.4%
|
1,506,672
|
$117,129,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
1,306,342
|
$101,555,000 | — | 30 Jun 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
1,115,790
|
$86,741,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.94%
|
984,288
|
$76,518,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.85%
|
889,999
|
$69,189,000 | — | 30 Jun 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
0.84%
|
885,000
|
$68,800,000 | — | 30 Jun 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.83%
|
872,292
|
$67,829,000 | — | 30 Jun 2021 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.78%
|
823,060
|
$64,015,572 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.69%
|
721,192
|
$56,065,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.68%
|
712,359
|
$55,379,000 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
0.63%
|
660,271
|
$51,329,000 | — | 30 Jun 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.61%
|
636,404
|
$49,474,000 | — | 30 Jun 2021 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.59%
|
615,580
|
$47,855,000 | — | 30 Jun 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.48%
|
508,304
|
$39,516,000 | — | 30 Jun 2021 | |
| ARK Investment Management LLC |
13F
|
Company |
0.48%
|
504,442
|
$39,215,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.44%
|
462,103
|
$35,924,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.43%
|
453,334
|
$35,241,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.43%
|
448,619
|
$34,875,000 | — | 30 Jun 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.4%
|
418,600
|
$32,542,000 | — | 30 Jun 2021 | |
| Consonance Capital Management LP |
13F
|
Company |
0.39%
|
409,301
|
$31,819,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.39%
|
403,793
|
$31,391,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.37%
|
388,210
|
$30,180,000 | — | 30 Jun 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.34%
|
359,753
|
$27,967,000 | — | 30 Jun 2021 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.32%
|
336,845
|
$26,186,000 | — | 30 Jun 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
334,471
|
$26,002,000 | — | 30 Jun 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.31%
|
328,750
|
$25,557,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.31%
|
324,696
|
$25,242,000 | — | 30 Jun 2021 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.28%
|
298,500
|
$23,205,000 | — | 30 Jun 2021 | |
| CIBC Asset Management Inc |
13F
|
Company |
0.26%
|
274,380
|
$21,330,000 | — | 30 Jun 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.22%
|
226,493
|
$17,608,000 | — | 30 Jun 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.22%
|
226,083
|
$17,576,000 | — | 30 Jun 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.19%
|
199,831
|
$15,535,000 | — | 30 Jun 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.18%
|
193,224
|
$15,021,000 | — | 30 Jun 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.18%
|
183,928
|
$14,299,000 | — | 30 Jun 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.17%
|
178,568
|
$13,882,000 | — | 30 Jun 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.17%
|
174,974
|
$13,602,000 | — | 30 Jun 2021 | |
| Korea Investment CORP |
13F
|
Company |
0.16%
|
170,341
|
$13,242,000 | — | 30 Jun 2021 | |
| Swiss National Bank |
13F
|
Company |
0.16%
|
166,600
|
$12,951,000 | — | 30 Jun 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.15%
|
162,389
|
$12,624,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.15%
|
162,017
|
$12,596,000 | — | 30 Jun 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.15%
|
154,194
|
$11,987,000 | — | 30 Jun 2021 |
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q3 2021
As of 30 Sep 2021,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
297 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,753,485 shares.
The largest 10 holders included
VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, SANDS CAPITAL MANAGEMENT, LLC, BlackRock Inc., FMR LLC, Capital Research Global Investors, Avoro Capital Advisors LLC, Bank of New York Mellon Corp, Point72 Asset Management, L.P., and STATE STREET CORP.
This page lists
297
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
315
Q3 2021 holders
297
Holder diff
-18
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.